Medicines Formulary

Reports

Drug name	NICE TAs	Comments
Memantine tablets	TA217 - Donepezil, galantamine, rivastigmine and memantine for the treatment of Alzheimer's disease	Dementia drugs ESCA
Mercaptopurine tablets		ESCA
Meritene shake (powder)		Prescribed for liver patients at request of UHB liver/dietetic team only. Liver/hepatobiliary and pancreatic conditions. Supported by RICaD.
Mesalazine (Octasa®)		Octasa is preferred brand of choice
Metanium ointment
Methadone hydrochloride		Palliative care only
Methadone mixture 1mg/ml	TA114 - Methadone and buprenorphine for the management of opiod dependence
Methotrexate		ILD - ESCA
Methotrexate 2.5mg tablets		Supported with an ESCA. Methotrexate tablets - use 2.5mg strength ONLY. Methotrexate injection - Metoject is APC preferred brand. Check cytotoxic disposal arrangements locally.
Methotrexate injections		Supported with an ESCA. Metoject is APC preferred brand. Check cytotoxic disposal arrangements locally.

First page
Previous page
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
Next page
Last page

Drug status key

Formulary drugs are allocated a traffic light status. This provides guidance on where clinical and prescribing responsibilities lie in regard to the initiation and maintenance of prescribing.

Grey

Positive NICE TA and/or awaiting local clarification on place in therapy. Please contact your medicines optimisation team for more information.

Red

Initiation and maintenance of prescribing by specialists only.

Amber

Initiation and maintenance of prescribing by specialists and transfer to primary care prescribing when appropriate, or in primary care following a specialists recommendation. Prior to initiation some medicines may require committee agreement or a framework to support safe transfer and maintenance.

Green

Initiation and maintenance of prescribing by specialists, GPs and other qualified clinicians.

Blue

Under review at University Hospitals Birmingham NHS Foundation Trust.